Save information for later
Sign Up

Learn About Cystectomy

Who are the top Cystectomy Local Doctors?

Henry Ford Health System

2799 W Grand Blvd, 
Detroit, MI 
 (11.7 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

James Peabody is an Urologist in Detroit, Michigan. Dr. Peabody and is rated as an Elite provider by MediFind in Cystectomy. His top areas of expertise are Prostate Cancer, Bladder Cancer, Familial Prostate Cancer, Prostatectomy, and Cystectomy. Dr. Peabody is currently accepting new patients.

Henry Ford Health System

2799 W Grand Blvd, 
Detroit, MI 
 (11.7 mi)
Languages Spoken:
English, Arabic, Italian
Accepting New Patients
Offers Telehealth

Firas Abdollah is an Urologist in Detroit, Michigan. Dr. Abdollah and is rated as an Advanced provider by MediFind in Cystectomy. His top areas of expertise are Prostate Cancer, Upper Tract Urothelial Carcinoma (UTUC), Urothelial Cancer, Prostatectomy, and Nephrectomy. Dr. Abdollah is currently accepting new patients.

 
 
 
 
Learn about our expert tiers
Learn More

Henry Ford Health System

19401 Hubbard Dr, 
Dearborn, MI 
 (19.7 mi)
Languages Spoken:
English
Accepting New Patients
Offers Telehealth

Naveen Kachroo is an Urologist in Dearborn, Michigan. Dr. Kachroo and is rated as an Experienced provider by MediFind in Cystectomy. His top areas of expertise are Kidney Stones, Urinary Tract Infection (UTI), Urinary Tract Infection in Children, Ureteroscopy, and Lithotripsy. Dr. Kachroo is currently accepting new patients.

What are the latest Cystectomy Clinical Trials?
Enfortumab Vedotin in Combination with Pembrolizumab for Locally Advanced And/or Node Positive Urothelial Carcinoma Prior to Surgery (EV-ECLIPSE)

Summary: This study will test whether enfortumab vedotin combined with pembrolizumab is an effective treatment for people with bladder cancer (urothelial carcinoma) involving the lymph nodes who are going to have surgery to remove their cancer (cystectomy). The researchers will look at whether treatment with enfortumab vedotin and pembrolizumab before surgery can get rid of cancer within the lymph nodes. T...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Discharge Medication Use Post-Operatively in GU Cancer Patients

Summary: The main purpose of this research study is to determine the amount of opioids that are taken after discharge following a cystectomy, nephrectomy (partial or total), or prostatectomy surgeries via a 30-day post- discharge opioid use and disposal survey. We will also evaluate the impact of an opioid disposal education pamphlet on proper disposal of unused opioids.